吡啶-2-甲酸鉻

吡啶-2-甲酸鉻
Ball and Stick model of chromium (III) picolinate	Spacefill model of chromium (III) picolinate
	IUPAC名; Tris(picolinate)chromium(III)
別名	2-吡啶甲酸鉻; 2-吡啶羧酸鉻; 吡啶-2-羧酸鉻
識別
CAS號	14639-25-9
PubChem	151932
ChemSpider	133913
SMILES	c1ccnc(c1)C(=O)[O-].c1ccnc(c1)C(=O)[O-].c1ccnc(c1)C(=O)[O-].[Cr+3];
InChI	1/3C6H5NO2.Cr/c38-6(9)5-3-1-2-4-7-5;/h31-4H,(H,8,9);/q;;;+3/p-3;
InChIKey	CBDQOLKNTOMMTL-DFZHHIFOAM
ChEBI	50369
性質
化學式	Cr(C6H4NO2)3
摩爾質量	418.33 g/mol g·mol⁻¹
	若非註明，所有數據均出自標準狀態（25 ℃，100 kPa）下。

吡啶-2-甲酸鉻（簡寫：CrPic₃）是一種化合物，用作營養補充劑以治療2型糖尿病，以及促進減肥。^[1] 它是紅粉色的化合物，最初於1917年報道。^[2]^[3]它難溶於水，在中性pH下的水中，溶解度為600 µmol/L。^[4]它和其它三價鉻化合物類似，化學性質上具有惰性，即在一般條件下穩定，它僅在較高溫度下分解。^[5]在較低的pH下，該配合物會游離出吡啶-2-甲酸和Cr³⁺離子。^[4]

參考文獻

^ Preuss, H. G.; Echard, B.; Perricone, N. V.; Bagchi, D.; Yasmin, T.; Stohs, S. J. Comparing metabolic effects of six different commercial trivalent chromium compounds. Journal of Inorganic Biochemistry. 2008, 102 (11): 1986–1990. PMID 18774175. doi:10.1016/j.jinorgbio.2008.07.012.
^ Vincent, John (2010). "Chromium: celebrating 50 years as an essential element?". Dalton Transactions. Royal Society of Chemistry. 39: 3787–3794. doi:10.1039/B920480F. PMID 20372701. Retrieved 20 March 2015.
^ Vincent, John. The Bioinorganic Chemistry of Chromium (III). Polyhedron (Elsevier B.V). 2001, 20: 1–26 [20 March 2015]. doi:10.1016/S0277-5387(00)00624-0. （原始內容存檔於2015-09-24）.
^ ^4.0 ^4.1 Feng, Weiyue (2007). "Chapter 6—The Transport of chromium (III) in the body: Implications for Function". In Vincent, John. The Nutritional Biochemistry of Chromium (III) (PDF). Amsterdam: Elsevier B.V. pp. 121–137. ISBN 978-0-444-53071-4. Retrieved 20 March 2015.
^ Abou–Gamra, Zeinab; Abdel–Messih, Michel. Correlation of thermal and spectral properties of chromium(III) picolinate complex and kinetic study of its thermal degradation. Journal of Thermal Analysis and Calorimetry (Springer Netherlands). 2014, 117 (2): 993–1000 [1 April 2015]. doi:10.1007/s10973-014-3768-5. （原始內容存檔於2019-07-30）.

拓展連結

[1] Preuss, H. G.; Echard, B.; Perricone, N. V.; Bagchi, D.; Yasmin, T.; Stohs, S. J. Comparing metabolic effects of six different commercial trivalent chromium compounds. Journal of Inorganic Biochemistry. 2008, 102 (11): 1986–1990. PMID 18774175. doi:10.1016/j.jinorgbio.2008.07.012.

[Cr50yr-2] Vincent, John (2010). "Chromium: celebrating 50 years as an essential element?". Dalton Transactions. Royal Society of Chemistry. 39: 3787–3794. doi:10.1039/B920480F. PMID 20372701. Retrieved 20 March 2015.

[Vincent2001-3] Vincent, John. The Bioinorganic Chemistry of Chromium (III). Polyhedron (Elsevier B.V). 2001, 20: 1–26 [20 March 2015]. doi:10.1016/S0277-5387(00)00624-0. （原始內容存檔於2015-09-24）.

[Feng-4] 4.0 ^4.1 Feng, Weiyue (2007). "Chapter 6—The Transport of chromium (III) in the body: Implications for Function". In Vincent, John. The Nutritional Biochemistry of Chromium (III) (PDF). Amsterdam: Elsevier B.V. pp. 121–137. ISBN 978-0-444-53071-4. Retrieved 20 March 2015.

[Abou2014-5] Abou–Gamra, Zeinab; Abdel–Messih, Michel. Correlation of thermal and spectral properties of chromium(III) picolinate complex and kinetic study of its thermal degradation. Journal of Thermal Analysis and Calorimetry (Springer Netherlands). 2014, 117 (2): 993–1000 [1 April 2015]. doi:10.1007/s10973-014-3768-5. （原始內容存檔於2019-07-30）.

[1]

[2]

[3]

[4]

[5]